Effect of early use of low-dose aspirin therapy on late-onset preeclampsia

References

• Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104.
   PubMed Web of Science ®Google Scholar
• LeFevre ML, US Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819–826.
   PubMed Web of Science ®Google Scholar
• Henderson JT, Whitlock EP, O’Connor E, et al. Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(10):695–703.
   PubMed Web of Science ®Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791–1798.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402–414.
   PubMed Web of Science ®Google Scholar
• Roberge S, Odibo AO, Bujold E. Aspirin for the prevention of preeclampsia and intrauterine growth restriction. Clin Lab Med. 2016;36(2):319–329.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Mone F, Mulcahy C, McParland P, et al. Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynecol. 2017;216(2):141.e1–141.e5.
   PubMed Web of Science ®Google Scholar
• Park F, Russo K, Williams P, et al. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. Ultrasound Obstet Gynecol. 2015;46(4):419–423.
   PubMed Web of Science ®Google Scholar
• Park FJ, Leung CH, Poon LC, et al. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol. 2013;53(6):532–539.
   PubMed Web of Science ®Google Scholar
• Joseph FA, Hyett JA, McGeechan K, et al. A new approach to developing birth weight reference charts: a retrospective observational study. Fetal Diagn Ther. 2017 [Jun 3];[1–8]. doi: 10.1159/000475662
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52(5):873–880.
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1–544.e12.
   PubMed Web of Science ®Google Scholar
• Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497–506.
   PubMed Web of Science ®Google Scholar
• Beaufils M, Uzan S, Donsimoni R, et al. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985;1(8433):840–842.
   PubMed Web of Science ®Google Scholar
• CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. CLASP (collaborative low-dose Aspirin Study in Pregnancy) collaborative group. Lancet. 1994;343(8898):619–629.
   PubMed Web of Science ®Google Scholar
• Whigham KA, Howie PW, Drummond AH, et al. Abnormal platelet function in pre-eclampsia. Br J Obstet Gynaecol. 1978;85(1):28–32.
   PubMedGoogle Scholar
• Groeneveld E, Lambers MJ, Lambalk CB, et al. Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data. Hum Reprod. 2013;28(6):1480–1488.
   PubMed Web of Science ®Google Scholar
• Schramm AM, Clowse ME. Aspirin for prevention of preeclampsia in lupus pregnancy. Autoimmune Dis. 2014;2014:920467.
   PubMedGoogle Scholar
• Masotti G, Galanti G, Poggesi L, et al. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet. 1979;2(8154):1213–1217.
   PubMed Web of Science ®Google Scholar
• Schiff E, Peleg E, Goldenberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 1989;321(6):351–356.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, et al. Time-dependent effects of ASA administration on blood pressure in healthy subjects. Chronobiologia. 1994;21(3–4):201–213.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Calvo C, et al. Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol. 2005;46(6):975–983.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 2005;46(4):1060–1068.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertens. 2009;22(8):896–903.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M, et al. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 1997;30(3 Pt 2):589–595.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434–443.
   PubMed Web of Science ®Google Scholar
• Onda K, Tong S, Beard S, et al. Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue Endothelial dysfunction. Hypertension. 2017;69(3):457–468.
   PubMed Web of Science ®Google Scholar
• Cluver CA, Walker SP, Mol BW, et al. Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol. BMJ Open. 2015;5(10):e008211.
   PubMed Web of Science ®Google Scholar